57th ASH Annual Meeting and Exposition (December 5-8, 2015)

You may search for particular presentations by typing key words, an author's name, or the title in the box below. You may specify the type of search, i.e. whether you want to see pages that contain any or all of the words you specify. The Boolean search option requires one of the keywords and, or, and not, as well as parentheses.

The search filters will allow you to restrict your search by date, session type, or abstract category and are all optional. Hold down the Ctrl key while selecting to choose more than one option in each list, or hold down the Shift key to select a range.

Search:

Restrict search results to:

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant

No Restriction
Thursday, December 3, 2015
Friday, December 4, 2015
Saturday, December 5, 2015
Sunday, December 6, 2015
Monday, December 7, 2015
Tuesday, December 8, 2015

No Restriction
Plenary
101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
102. Regulation of Iron Metabolism
112. Thalassemia and Globin Gene Regulation
113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science
114. Hemoglobinopathies, Excluding Thalassemia – Clinical
201. Granulocytes, Monocytes and Macrophages
203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
301. Platelet Activation and Biochemistry
302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
311. Disorders of Platelet Number or Function
321. Blood Coagulation and Fibrinolytic Factors
322. Disorders of Coagulation or Fibrinolysis
331. Pathophysiology of Thrombosis
332. Antithrombotic Therapy
401. Basic Science and Clinical Practice in Blood Transfusion
501. Hematopoietic Stem and Progenitor Biology
503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control
504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
508. Bone Marrow Failure
601. Chromosomal Rearrangements and DNA Repair
602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
603. Oncogenes and Tumor Suppressors
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases
605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases
612. Acute Lymphoblastic Leukemia: Clinical Studies
613. Acute Myeloid Leukemia: Clinical Studies
614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
621. Hodgkin Lymphoma: Biology, excluding Therapy
622. Non-Hodgkin Lymphoma: Biology, excluding Therapy
623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models
624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents
631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
632. Chronic Myeloid Leukemia: Therapy
634. Myeloproliferative Syndromes: Clinical
635. Myeloproliferative Syndromes: Basic Science
636. Myelodysplastic Syndromes – Basic and Translational Studies
637. Myelodysplastic Syndromes – Clinical Studies
641. CLL: Biology and Pathophysiology, excluding Therapy
642. CLL: Therapy, excluding Transplantation:
651. Myeloma: Biology and Pathophysiology, excluding Therapy
652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
653. Myeloma: Therapy, excluding Transplantation
661. Malignant Stem and Progenitor Cells
701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
703. Adoptive Immunotherapy
711. Cell Collection and Processing
721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
731. Clinical Autologous Transplantation: Results
732. Clinical Allogeneic Transplantation: Results
801. Gene Therapy and Transfer
802. Chemical Biology and Experimental Therapeutics
901. Health Services and Outcomes Research – Non-Malignant Conditions
902. Health Services and Outcomes Research – Malignant Diseases
Junior Researcher Symposium
Trainee Day
Trainee Simultaneous Didactic Session
Training Program Directors Workshop

57th ASH Annual Meeting and Exposition (December 5-8, 2015)

Restrict search results to:

Meeting Program